Evaluating Mass Spectrometry as a Potential Early Ovarian Cancer Recurrence Detection Method Using Bottom-Up Proteomic Analysis of Biomarker CA125 (MUC16)

Loading...
Thumbnail Image

Authors

Schroeder, Lia A.

Issue Date

2022

Type

Presentation

Language

en_US

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

High-grade serous ovarian cancer (HGSOC) is a common, recurring form of ovarian cancer, currently detected using a double-determinant immunoassay. This method analyzes resurging levels of the cancer biomarker CA125, which constitutes <1% of the larger mucin protein, MUC16, contained within a tandem repeat section (Figure 1). While the current detection method is effective and widely used, applying targeted mass spectrometry could allow for more accurate and reliable identification and quantification of low abundance proteins, such as MUC16 from small samples.

Description

1 Broadside. 48"W x 36"H

Citation

Publisher

Kalamazoo, Mich. : Kalamazoo College

License

U.S. copyright laws protect this material. Commercial use or distribution of this material is not permitted without prior written permission of the copyright holder.

Journal

Volume

Issue

PubMed ID

DOI

ISSN

EISSN